Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Tumori
|
June 9, 2012
Clinical response after sorafenib for hepatocellular carcinoma in elderly patients: a report of two cases
Francesca Spada, Michela Squadroni, Katia Lorizzo, et al.
Expert Opinion on Therapeutic Targets
|
March 22, 2006
Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice
Mario Scartozzi, Chiara Pierantoni, Rossana Berardi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 23, 2020
Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
Vincenzo Di Noia, Alessandro D'Aveni, Michela Squadroni, et al.
Critical Reviews in Oncology/Hematology
|
July 12, 2017
Cholangiocarcinoma
Michela Squadroni, Luca Tondulli, Gemma Gatta, et al.
Medical Oncology (Northwood, London, England)
|
February 13, 2013
FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials
Giordano Domenico Beretta, Fausto Petrelli, Sergio Stinco, et al.
American Journal of Clinical Oncology
|
October 9, 2007
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin
Stefano Cascinu, Mario Scartozzi, Giovanna Carbonari, et al.
Cancer Treatment Reviews
|
December 7, 2010
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas
Nicola Fazio, Saverio Cinieri, Katia Lorizzo, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2008
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer
Katia Lorizzo, Nicola Fazio, Davide Radice, et al.
Cancer Treatment Reviews
|
June 10, 2006
Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review
Rossana Berardi, Berardi Rossana, Mario Scartozzi, et al.
Journal of Autoimmunity
|
July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Lorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Tumori
|
June 9, 2012
Clinical response after sorafenib for hepatocellular carcinoma in elderly patients: a report of two cases
Francesca Spada, Michela Squadroni, Katia Lorizzo, et al.
Expert Opinion on Therapeutic Targets
|
March 22, 2006
Anti-EGFR strategies as an incremental step for the treatment of colorectal cancer patients: moving from scientific evidence to clinical practice
Mario Scartozzi, Chiara Pierantoni, Rossana Berardi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 23, 2020
Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?
Vincenzo Di Noia, Alessandro D'Aveni, Michela Squadroni, et al.
Critical Reviews in Oncology/Hematology
|
July 12, 2017
Cholangiocarcinoma
Michela Squadroni, Luca Tondulli, Gemma Gatta, et al.
Medical Oncology (Northwood, London, England)
|
February 13, 2013
FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials
Giordano Domenico Beretta, Fausto Petrelli, Sergio Stinco, et al.
American Journal of Clinical Oncology
|
October 9, 2007
COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin
Stefano Cascinu, Mario Scartozzi, Giovanna Carbonari, et al.
Cancer Treatment Reviews
|
December 7, 2010
Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas
Nicola Fazio, Saverio Cinieri, Katia Lorizzo, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2008
Simplified FOLFIRI in pre-treated patients with metastatic gastric cancer
Katia Lorizzo, Nicola Fazio, Davide Radice, et al.
Cancer Treatment Reviews
|
June 10, 2006
Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review
Rossana Berardi, Berardi Rossana, Mario Scartozzi, et al.
Journal of Autoimmunity
|
July 28, 2020
Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
Lorenzo M Canziani, Serena Trovati, Enrico Brunetta, et al.
Page
of 2